Logo of Dallah Healthcare
Saudi Arabia’s Capital Market Authority (CMA) approved Dallah Healthcare Co.’s request to increase its capital to SAR 1.22 billion from SAR 1.02 billion. 
In a statement, the CMA said the increase will be carried out through the distribution of one bonus share for every five existing shares (1-to-5) held. The eligible shareholders are those registered with the Securities Depository Center (Edaa) at the end of the second trading day following the record date, which will be determined by the company’s board of directors at a later date.
The capital increase will be financed through the capitalization of SAR 109.53 million from the share premium account and SAR 93.61 million from the statutory reserve, increasing the number of shares to 121.89 million from 101.57 million through the issuance of 20.31 million new shares.
The CMA added that the extraordinary general meeting (EGM) must be held within six months from the date of the approval, and the company must complete all related regulatory procedures and requirements.
According to Argaam data, Dallah Healthcare’s board of directors recommended in March a 20% capital increase through a 1-for-5 bonus share distribution.
Capital Increase Details
Current Capital
SAR 1.01 bln
CurrentNo. of Shares
101.58 mIn
Post-Increase Capital
SAR 1.21 bln
No. of Shares Post-Increase
121.89 bIn
Capital Increase
20%
Reason
To support the company’s capital so it aligns with total assets, and strengthen its financial position.
No. of Shares Granted
1-to-5 bonus shares
Nature, Value of Reserves to be Used
SAR 93.61 mln from the statutory reserves; SAR 109.53 mln from the share premium.
Record Date
For shareholders on the record date, and for those registered with Edaa, at the end of second trading day following the record date.
Logo of Dallah Healthcare
Saudi Arabia’s Capital Market Authority (CMA) approved Dallah Healthcare Co.’s request to increase its capital to SAR 1.22 billion from SAR 1.02 billion.
In a statement, the CMA said the increase will be carried out through the distribution of one bonus share for every five existing shares (1-to-5) held. The eligible shareholders are those registered with the Securities Depository Center (Edaa) at the end of the second trading day following the record date, which will be determined by the company’s board of directors at a later date.
The capital increase will be financed through the capitalization of SAR 109.53 million from the share premium account and SAR 93.61 million from the statutory reserve, increasing the number of shares to 121.89 million from 101.57 million through the issuance of 20.31 million new shares.
The CMA added that the extraordinary general meeting (EGM) must be held within six months from the date of the approval, and the company must complete all related regulatory procedures and requirements.
According to Argaam data, Dallah Healthcare’s board of directors recommended in March a 20% capital increase through a 1-for-5 bonus share distribution.
Capital Increase Details
Current Capital
SAR 1.01 bln
CurrentNo. of Shares
101.58 mIn
Post-Increase Capital
SAR 1.21 bln
No. of Shares Post-Increase
121.89 bIn
Capital Increase
20%
Reason
To support the company’s capital so it aligns with total assets, and strengthen its financial position.
No. of Shares Granted
1-to-5 bonus shares
Nature, Value of Reserves to be Used
SAR 93.61 mln from the statutory reserves; SAR 109.53 mln from the share premium.
Record Date
For shareholders on the record date, and for those registered with Edaa, at the end of second trading day following the record date.
